FMC
36
3
CHD
53
-3
GT
46
3
HUM
30
3
NSC
62
2
MRK
53
3
MS
50
-8
DLTR
31
3
QRVO
33
-3
ABT
57
-9
AN
49
2
JBHT
49
3
ICE
64
-5
DTE
56
-7
JPM
53
-2
STZ
54
-4
NUE
50
3
ETR
68
-3
LMT
40
-5
MCD
63
-4
FMC
36
3
CHD
53
-3
GT
46
3
HUM
30
3
NSC
62
2
MRK
53
3
MS
50
-8
DLTR
31
3
QRVO
33
-3
ABT
57
-9
AN
49
2
JBHT
49
3
ICE
64
-5
DTE
56
-7
JPM
53
-2
STZ
54
-4
NUE
50
3
ETR
68
-3
LMT
40
-5
MCD
63
-4
Financhill
Back

Concord Acquisition Corp II Vs. Mirum Pharmaceuticals Industry Stock Comparison

Sell
44

CNDA
Concord Acquisition Corp II

Last Price:
10.40
Seasonality Move:
1.71%
Sell
40

MIRM
Mirum Pharmaceuticals

Last Price:
39.37
Seasonality Move:
5.99%
Sell
44
Concord Acquisition Corp II (CNDA) is a Sell

Is Concord Acquisition Corp II a Buy, Sell or Hold?

  • The current Concord Acquisition Corp II [CNDA] share price is $10.40. The Score for CNDA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CNDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy, Sell or Hold?

  • The current Mirum Pharmaceuticals [MIRM] share price is $37.93. The Score for MIRM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • MIRM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNDA Stock Price Chart

What is Concord Acquisition Corp II's stock price today?

  • The Concord Acquisition Corp II share price today is $10.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNDA is experiencing selling pressure, which indicates risk of future bearish movement.

MIRM Stock Price Chart

What is Mirum Pharmaceuticals's stock price today?

  • The Mirum Pharmaceuticals share price today is $37.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight selling pressure.

CNDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 43.25 Sell
Chaikin Money Flow: -500 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.41 - 10.57) Sell
Bollinger Bands (100): (10.48 - 10.6) Sell

MIRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 36.81 Sell
Chaikin Money Flow: -512602 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.29 - 42.71) Sell
Bollinger Bands (100): (27.1 - 41.32) Buy

CNDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.44 Sell
20-day SMA: 10.48 Sell
50-day SMA: 10.51 Sell
200-day SMA: 10.5 Sell
8-day EMA: 10.44 Sell
20-day EMA: 10.47 Sell
50-day EMA: 10.5 Sell
200-day EMA: 10.47 Sell

MIRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 41.55 Sell
50-day SMA: 40.65 Sell
200-day SMA: 31.03 Buy
8-day EMA: 40.34 Sell
20-day EMA: 40.95 Sell
50-day EMA: 39.41 Sell
200-day EMA: 32.8 Buy

Concord Acquisition Corp II Earnings Growth & CNDA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.

Concord Acquisition Corp II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Mirum Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):